✦ LIBER ✦

607 NCIC CTG IND.196: Phase I Study of Foretinib (GSK1363089) and Erlotinib in Patients with Advanced Pretreated NSCLC

✍ Scribed by Leighl, N.B.; Tsao, M.S.; Ho, C.; Shepherd, F.A.; Murray, N.; Goffin, J.; Nicholas, G.; Seymour, L.; Goss, G.D.; Bradbury, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NCIC CTG IND 98: a phase I dose escalati

✍ Bjarnason, G.; Charpentier, D.; Wong, R.; Goel, R.; Smith, M.; Abugaber, A.; Mat 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 144 KB

408 A phase II study of erlotinib in com

✍ E. Winquist; D. Soulieres; E. Chen; M. Tsao; M. Klein; G. Pond; J. Dancey; E. Ei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A phase I study of T900607 given once ev

✍ K.A. Gelmon; K. Belanger; C. Britton; D. Soulières; S. Janke; J. Dionne; J. Powe 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A phase I study of ZD0473 and docetaxel

✍ K.A. Gelmon; D. Stewart; D. Ayers; D. Fry; L. Douglas; L.W. McIntosh; L.K. Seymo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 172 KB

NCIC CTG IND.122: a phase I/II pharmacok

✍ Goss, G.; Hirte, H.; Batist, G.; Miller, W.; Stewart, D.; Matthews, S.; Seymour, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

607 POSTER Impressive anti-tumor activit

✍ M. Beeram; J.S. De Bono; E.K. Rowinsky; P. O'Rourke; A. Ricart; L.A. Hammond; A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB